Point-of-care CAR T-cell Manufacturing
Join us for this podcast discussing the promises and challenges of academic and point-of-care CAR T-cell manufacturing with Dr Anna Sureda, president of EBMT (European Society for Blood and Marrow Transplantation).
Dr Sureda provides her expert point of view on how CAR T-cells produced in academic centres may enhance patient access to CAR-T treatment, reducing costs and turnround times for production, and on the regulatory and quality issues linked to decentralized manufacturing of CAR T-cells.
Discover the current European landscape for academic CAR-T production, the evidence and experiences…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.